Why isn’t CAR-T Therapy Revolutionizing the Fight Against GI Cancers? 17 Trial Insights from ASCO GI 2025 Gastrointestinal 4 Mins Read Introduction: Recent data from the American Society of Clinical Oncology (ASCO) GI Cancers Symposium 2025, as detailed in their educational…
Promising Phase 2 Results for Zanidatamab in HER2+ Biliary Tract Cancer: ASCO 2024 Update ASCO Annual Meeting 2 Mins Read Author: Dr. Shubham Pant, MD – MD Anderson Overview: At the ASCO 2024 conference, Dr. Shubham Pant, MD – MD…
